Rareș-Mario Borșa

Mr. Rareș-Mario Borșa

Dental Medicine Faculty, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Cluj, Romania
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Rareș-Mario BorșaRareș-Mario Borșa
Rareș-Mario Borșa
Valentin TomaValentin Toma
Valentin Toma
AOAnca Onaciu
Anca Onaciu
CMCristian Silviu Moldovan
Cristian Silviu Moldovan
RMRadu Marginean
Radu Marginean
RSRares Ionut Stiufiuc
Rares Ionut Stiufiuc
Cancer still represents one of the biggest challenges in current medical practice. Among different types of cancer, oral cancer has a huge impact on patients due to its great visibility, which is more likely to create social stigma and increased anxiety. New early diagnose methods are still needed to improve treatment efficiency and patients’ life quality. Raman/SERS (Surface Enhanced Raman Spectroscopy) spectroscopy has a unique and powerful potential for detecting specific molecules that can become priceless biomarkers in different pathologies, such as oral cancer. In this study, a batch of saliva samples obtained from a group of 17 patients with oro-maxillofacial pathologies compared with saliva samples from 18 healthy donors using the aforementioned methods were evaluated. At the same time, opiorphin, potassium thiocyanate and uric acid were evaluated as potential specific biomarkers for oro-maxillofacial pathologies using multivariate analysis. A careful examination of SERS spectra collected on saliva samples showed that the spectra are dominated by the vibrational bands of opiorphin, potassium thiocyanate and uric acid. Given the fact that all these small molecules are found in very small amounts, we filtrated all the samples to get rid of large molecules and to improve our analysis. By using solid plasmonic substrates, we were able to gain information about molecular concentration and geometry of interaction. On the other hand, the multivariate analysis of the salivary spectra contributed to developing a new detection method for oral cancer.

12 January 2024 in Biosensors
Verified
Journal Article
Open access
PDF file
LDLuca David
Luca David
AOAnca Onaciu
Anca Onaciu
Valentin TomaValentin Toma
Valentin Toma
Rareș-Mario BorșaRareș-Mario Borșa
Rareș-Mario Borșa
CMCristian Silviu Moldovan
Cristian Silviu Moldovan
RSRares Ionut Stiufiuc
Rares Ionut Stiufiuc
This study delves into the intricate interaction between DNA and nanosystems, exploring its potential implications for biomedical applications. The focus lies in understanding the adsorption geometry of DNA when in proximity to plasmonic nanoparticles, utilizing ultrasensitive vibrational spectroscopy techniques. Employing a combined Raman-SERS analysis, we conducted an in-depth examination to clarify the molecular geometry of interactions between DNA and silver nanoparticles. Our findings also reveal distinctive spectral features regarding DNA samples due to their distinctive genome stability. To understand the subtle differences occurring between normal and cancerous DNA, their thermal stability was investigated by means of SERS measurement performed before and after a thermal treatment at 94 °C. It was proved that thermal treatment did not affect DNA integrity in the case of normal cells. On the other hand, due to epimutation pattern that characterizes cancerous DNA, variations between spectra recorded before and after heat treatment were observed, suggesting genome instability. These findings highlight the potential of DNA analysis using SERS for cancer detection. They demonstrate the applicability of this approach to overcoming challenges associated with low DNA concentrations (e.g., circulating tumor DNA) that occur in biofluids. In conclusion, this research contributes significant insights into the nanoscale behavior of DNA in the presence of nanosystems.

29 December 2022 in Sensors
Verified
Journal Article
Open access
PDF file
AOAnca Onaciu
Anca Onaciu
Valentin TomaValentin Toma
Valentin Toma
CMCristian Silviu Moldovan
Cristian Silviu Moldovan
Adrian Bogdan ȚiguAdrian Bogdan Țigu
Adrian Bogdan Țigu
Diana M CenariuDiana M Cenariu
Diana M Cenariu
RSRares Ionut Stiufiuc
Rares Ionut Stiufiuc
DNA methylation is a crucial epigenetic hallmark of cancer development but the experimental methods able to prove nanoscale modifications are very scarce. Over time, Raman and its counterpart, surface-enhanced Raman scattering (SERS), became one of the most promising techniques capable to investigate nanoscale modifications of DNA bases. In our study, we employed Raman/SERS to highlight the differences between normal and leukemia DNA samples and to evaluate the effects of a 5-azacytidine treatment on leukemia cells. To obtain spectral information related to DNA base modifications, a DNA incubation step of 4 min at 94 °C, similar to the one performed in the case of RT-PCR experiments, was conducted prior to any measurements. In this way, reproducible Raman/SERS spectra were collected for all genomic DNA samples. Our Raman results allowed discrimination between normal and cancer DNAs based on their different aggregation behavior induced by the distinct methylation landscape present in the DNA samples. On the other hand, the SERS spectra collected on the same DNA samples show a very intense vibrational band located at 1008 cm−1 assigned to a rocking vibration of 5-methyl-cytosine. The intensity of this band strongly decreases in cancer DNA due to the modification of the methylation landscape occurring in cancers. We believe that under controlled experimental conditions, this vibrational band could be used as a powerful marker for demonstrating epigenetic reprogramming in cancer by means of SERS.

13 February 2026 in Experimental Neurology
Verified
Journal Article
Open access
LDLuca David
Luca David
Rareș-Mario BorșaRareș-Mario Borșa
Rareș-Mario Borșa
AOAnca Onaciu
Anca Onaciu
GVGeorge Voicescu
George Voicescu
CMCristian Silviu Moldovan
Cristian Silviu Moldovan
AGAdela Golea
Adela Golea
This systematic review explores the application of Raman spectroscopy (RS) in traumatic brain injury (TBI) research, emphasizing the need for innovative and efficient diagnostic tools. The development of such techniques aims to alleviate healthcare costs while providing timely assessment of injury severity. A systematic literature search for the use of RS in TBI was conducted in PubMed, Scopus, and Web of Science from inception to July 28, 2025, following PRISMA guidelines. We included only original English-language studies (animals and humans) in free full-text format. Risk of bias was assessed using specific tools for both animal and human models. Findings were classified according to the cohorts, and spectroscopic technique alongside their particularities. The initial search found 261 articles, with 26 studies meeting the inclusion criteria. Among them: 15 were animal studies and 11 translational/human-relevant studies. Among animal studies, 3 focused on in-situ monitoring and TBI classification, 2 on blast-induced models, 5 on blood biomarker analysis, 2 on retinal-based point-of-care diagnostics, and 3 on Raman microscopy. The translational research studies aimed to identify and validate TBI biomarkers for developing future diagnostic strategies in human patients. RS distinguished injured from control tissue through spectral changes reflecting protein and lipid alterations and differentiated lesion areas by revealing astrogliosis-related reorganization. Instantaneous in-situ RS devices achieved >92% accuracy in severity classification and detected biomarker-related molecular changes. Point-of-care RS platforms using lateral flow strips enabled rapid detection of specific TBI biomarkers (GFAP, NAA, NSE, S100B, UCH-L1), showing performance comparable to ELISA while offering faster, simpler, and cost-efficient testing.

16 December 2024 in Sensors
Verified
Journal Article
Open access
PDF file
Rareș-Mario BorșaRareș-Mario Borșa
Rareș-Mario Borșa
Valentin TomaValentin Toma
Valentin Toma
MNMelania-Teodora Nășcuțiu
Melania-Teodora Nășcuțiu
AOAnca Onaciu
Anca Onaciu
ICIoana Maria Colceriu-Simon
Ioana Maria Colceriu-Simon
MBMihaela Baciut
Mihaela Baciut
The use of Raman spectroscopy, particularly surface-enhanced Raman spectroscopy (SERS), offers a powerful tool for analyzing biochemical changes in biofluids. This study aims to assess the modifications occurring in saliva collected from patients before and after exposure to cone beam computed tomography (CBCT) and computed tomography (CT) imaging. SERS analysis revealed significantly amplified spectra in post-imaging samples compared to pre-imaging samples, with pronounced intensification of thiocyanate and opiorphin bands, which, together with proteins, dominated the spectra. The changes were more pronounced in the case of CT as compared to CBCT, probably due to the use of a high radiation dose in the case of the first-mentioned technique. These findings underscore the impact of CBCT and CT on salivary composition, highlighting the relevance of SERS as a sensitive method for detecting subtle molecular changes in biofluids post-radiation exposure. This study’s results emphasize the importance of monitoring biochemical markers in patients undergoing diagnostic imaging to better understand the systemic effects of ionizing radiation.

17 October 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MAModog Andrei
Modog Andrei
AOAnca Onaciu
Anca Onaciu
Rareș-Mario BorșaRareș-Mario Borșa
Rareș-Mario Borșa
Valentin TomaValentin Toma
Valentin Toma
GSGabriela Fabiola Stiufiuc
Gabriela Fabiola Stiufiuc
RSRadu Razvan Scurtu
Radu Razvan Scurtu
Obesity in the 21st century has become a global epidemic owing to its heterogeneous aetiology and clinical presentation, as well as the development of associated comorbidities such as cardiovascular disease, type2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea, and obesity-related cancers. Notably, cardiovascular disease and diabetes are major contributors to obesity-associated morbidity and mortality. Current diagnostic approaches rely predominantly on anthropometric measurements, which have proven limited in their ability to provide accurate and clinically meaningful stratification of patients with obesity. Consequently, obesity treatments, including metabolic surgery and pharmacological therapies, remain insufficiently tailored to the wide variability in obesity-related genotypes, phenotypes, and endotypes. In this context, a personalised medical approach offers considerable promise. A clear overview of currently effective diagnostic tools and treatments, as well as future possibilities, is therefore needed. Recent developments in precision medicine, multi-omics, biomarkers, and advanced diagnostic technologies may facilitate improved patient stratification and support more individualized therapeutic strategies. Together, these approaches may contribute to a more comprehensive, evidence-based, and patient-centered framework for the prevention, diagnosis, and management of obesity and its complications.